Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Trends in dermatology].

A Campanelli1, V Piguet

  • 1Service de dermatologie HUG, 1211 Genève 14.

Revue Medicale Suisse
|March 4, 2008
PubMed
Summary
This summary is machine-generated.

This review highlights 2007 dermatology advances, including filaggrin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterising the social interaction style of autism in young adult males with fragile X syndrome.

Journal of intellectual disability research : JIDR·2024
Same author

Features of paradoxical psoriasis and risk factors in inflammatory bowel disease: A systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Adverse Drug Reactions Due to Opioid Use in Oldest-Old Patients Visiting the Emergency Unit of the Geneva Geriatric Hospital.

The Journal of frailty & aging·2022
Same author

Treatment of severe hidradenitis Suppurativa and Fistulizing Crohn's disease with Guselkumab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Use of thermal imaging and a dedicated wound-imaging smartphone app as an adjunct to staging hidradenitis suppurativa.

The British journal of dermatology·2021
Same author

Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidence.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
See all related articles

Area of Science:

  • Dermatology
  • Immunodermatology
  • Oncology

Context:

  • Atopic dermatitis research has identified the epidermal protein filaggrin as a key factor.
  • Biological therapies are being investigated for atopic dermatitis, including off-label applications.
  • The quadrivalent human papilloma vaccine was introduced, offering protection against condyloma and cervical cancers.

Purpose:

  • To summarize significant advancements in dermatological research and treatment from 2007.
  • To highlight the role of filaggrin in atopic dermatitis.
  • To discuss the impact of the human papilloma vaccine and report on adverse treatment effects.

Summary:

  • Filaggrin's crucial role in atopic dermatitis is confirmed by multiple studies.
  • Evaluation of biologicals for atopic dermatitis is ongoing, with exploration of off-label uses.

Related Experiment Videos

  • The quadrivalent human papilloma vaccine introduction is expected to reduce condyloma and prevent cervical cancers.
  • Unwarranted side effects associated with dermatological treatments were also noted.

    • Impact:

    • Advances in understanding atopic dermatitis pathogenesis.
    • Potential for new therapeutic strategies for inflammatory skin conditions.
    • Public health benefits through widespread vaccination against human papilloma virus.
    • Improved patient safety through awareness of potential treatment side effects.